PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Macrogol compound - Faecal impaction (adults)
PAD Profile : Macrogol compound - Faecal impaction (adults) Important
Brand Names Include :
Laxido, Movicol, Cosmocol, Macilax, Molaxole, Strigol, Moviprep, Plenvu
Important Information :
Prescribe as macrogol compound oral powder sachets
Traffic Light Status
Status 1 of 3.
Status :
Green
Important
Formulations :
- Sachets (powder)
Important Information :
Prescribe as macrogol compound oral powder sachets. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
Documents :
Status 2 of 3.
Status :
Red
Important
Formulations :
- Sachets (powder)
Important Information :
Moviprep. Off-label use. SASH reserve for paediatrics only. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
Documents :
Status 3 of 3.
Status :
Red
Important
Formulations :
- Sachets (powder)
Important Information :
Plenvu. Off-label use. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- Constipation
- Faecal impaction (children)
- Pre-operative bowel cleansing (adults)
- Pre-operative bowel cleansing (children)
- Gut decontamination where activated charcoal not s
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
03 July 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
01. Gastro-Intestinal System
01.06.04. Osmotic laxatives